कृपया अन्य खोज का प्रयास करें
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company’s pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead compound is Otenaproxesul, an NSAID that releases hydrogen sulfide for treating post-operative pain, migraine, acute musculoskeletal pain, dysmenorrhea, gout, and dental pain. In addition, its products comprise ATB-352, which is in preclinical stage for acute pain. The company was incorporated in 2009 and is headquartered in Toronto, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Louis Joseph Ignarro | 82 | - | Member of Scientific Advisory Board |
Richard H. Hunt | - | - | Member of Scientific Advisory Board |
William C. Sessa | - | - | Member of Scientific Advisory Board |
Daniel Kalman Podolsky | 71 | - | Member of Scientific Advisory Board |
Philip M. Sherman | - | - | Member of Scientific Advisory Board |
Gilberto de Nucci | - | - | Member of Scientific Advisory Board |
Andre Gerald Buret | - | - | Member of Scientific Advisory Board |
Giuseppe Cirino | - | - | Member of Scientific Advisory Board |
Peter B. Ernst | - | - | Member of Scientific Advisory Board |
Francis Chan | - | - | Member of Clinical Advisory Board |
Derek Gilroy | - | - | Member of Scientific Advisory Board |
James Scheiman | - | - | Member of Clinical Advisory Board |
Angel Lanas | - | - | Member of Clinical Advisory Board |
Andrew Kenneth Williams Powell | 66 | 2018 | Member of Advisory Board |
Angus C. Russell | 68 | 2018 | Member of Advisory Board |
J. Carter Thorne | - | 2014 | Member of Clinical Advisory Board |
Dominique P. Monnet | 63 | 2018 | Member of Advisory Board |
Donald D. Haut | 58 | 2021 | Partnering Advisory Team |
Harvey Schipper | - | 2021 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है